In cancer therapy-induced stomatitis, the mechanism has been proposed whereby inflammatory cytokines released from immune cell activation (IL-1β is a representative inflammatory cytokine) damage the oral epithelium (Lalla et al. The gene discussed is IL1B; the disease is stomatitis.